Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`PTO Form 1957 (Rev 10/2011)
`
`OMB No. 0651-0050 (Exp 09/20/2020)
`
`Response to Office Action
`
`Input Field
`
`SERIAL NUMBER
`
`LAW OFFICE ASSIGNED
`
`MARK SECTION
`
`MARK
`
`LITERAL ELEMENT
`
`STANDARD CHARACTERS
`
`USPTO-GENERATED IMAGE
`
`MARK STATEMENT
`
`The table below presents the data as entered.
`
`Entered
`
`79232007
`
`LAW OFFICE 108
`
`https://tmng-al.uspto.gov/resting2/api/img/79232007/large
`
`AMIDI
`
`YES
`
`YES
`
`The mark consists of standard characters, without claim to any particular font style,
`size or color.
`
`GOODS AND/OR SERVICES SECTION (005)(no change)
`
`GOODS AND/OR SERVICES SECTION (009)(no change)
`
`GOODS AND/OR SERVICES SECTION (010)(no change)
`
`GOODS AND/OR SERVICES SECTION (042)(current)
`
`INTERNATIONAL CLASS
`
`DESCRIPTION
`
`042
`
`Providing scientific and technological services and research and design relating thereto, namely, research and design in the field of in-vitro
`diagnostics, medical research and scientific research information in the field of pharmaceuticals and clinical trials; medical research and
`scientific study and research, namely, scientific and biotechnological facilities and research for the health care with regard to the production,
`validation, development, storage, transport, and use in an electronic device, consisting of one or more chips, integrated pharmaceutical
`compositions and in-vitro analysis - and diagnostic tools; designing, installing, maintaining, developing and updating software, mobile
`software applications and computer software platforms; consultancy and providing information regarding the aforesaid services, including
`provided via electronic networks such as the internet
`
`GOODS AND/OR SERVICES SECTION (042)(proposed)
`
`INTERNATIONAL CLASS
`
`TRACKED TEXT DESCRIPTION
`
`042
`
`Providing scientific and technological services and research and design relating thereto, namely, research and design in the field of in-vitro
`diagnostics, medical research and scientific research information in the field of pharmaceuticals and clinical trials; medical research and
`scientific study and research, namely, scientific and biotechnological facilities and research for the health care with regard to the production,
`validation, development, storage, transport, and use in an electronic device, consisting of one or more chips, integrated pharmaceutical
`compositions and in-vitro analysis - and diagnostic tools; medical research and scientific study and research in scientific and biotechnological
`facilities, namely, research in health care with regard to the production, validation, development, storage, transport, and use of an electronic
`device consisting of one or more chips, integrated pharmaceutical compositions and in-vitro analysis, and diagnostic tools; designing,
`installing, maintaining, developing and updating software, mobile software applications and computer software platforms; consultancy and
`providing information regarding the aforesaid services, including provided via electronic networks such as the internet
`
`FINAL DESCRIPTION
`
`Providing scientific and technological services and research and design relating thereto, namely, research and design in the field of in-vitro
`diagnostics, medical research and scientific research information in the field of pharmaceuticals and clinical trials; medical research and
`scientific study and research in scientific and biotechnological facilities, namely, research in health care with regard to the production,
`
`

`

`validation, development, storage, transport, and use of an electronic device consisting of one or more chips, integrated pharmaceutical
`compositions and in-vitro analysis, and diagnostic tools; designing, installing, maintaining, developing and updating software, mobile software
`applications and computer software platforms; consultancy and providing information regarding the aforesaid services, including provided via
`electronic networks such as the internet
`
`GOODS AND/OR SERVICES SECTION (044)(no change)
`
`ADDITIONAL STATEMENTS SECTION
`
`TRANSLATION
`
`The wording AMIDI has no meaning in a foreign language.
`
`SIGNIFICANCE OF MARK
`
`NEW ATTORNEY SECTION
`
`NAME
`
`FIRM NAME
`
`AMIDI appearing in the mark has no significance nor is it a term of art in the
`relevant trade or industry or as used in connection with the goods/services/collective
`membership organization listed in the application, or any geographical significance.
`
`Martin W. Schiffmiller
`
`Kirschstein Israel Schiffmiller & Pieron
`
`OTHER APPOINTED ATTORNEY
`
`Alan Israel and Lisa A. Pieroni
`
`STREET
`
`CITY
`
`STATE
`
`ZIP/POSTAL CODE
`
`COUNTRY
`
`PHONE
`
`FAX
`
`EMAIL
`
`425 Fifth Avenue 5th Floor, Suite 501
`
`New York
`
`New York
`
`10016-2223
`
`United States
`
`2126973750
`
`2125079153
`
`mws@kirschsteinlaw.com
`
`AUTHORIZED EMAIL COMMUNICATION
`
`Yes
`
`CORRESPONDENCE SECTION
`
`ORIGINAL ADDRESS
`
`NEW CORRESPONDENCE SECTION
`
`GEVERS
`Holidaystraat 5
`1831 Diegem
`BE
`
`NAME
`
`FIRM NAME
`
`STREET
`
`CITY
`
`STATE
`
`ZIP/POSTAL CODE
`
`COUNTRY
`
`PHONE
`
`FAX
`
`EMAIL
`
`Martin W. Schiffmiller
`
`Kirschstein Israel Schiffmiller & Pieron
`
`425 Fifth Avenue 5th Floor, Suite 501
`
`New York
`
`New York
`
`10016-2223
`
`United States
`
`2126973750
`
`2125079153
`
`mws@kirschsteinlaw.com
`
`AUTHORIZED EMAIL COMMUNICATION
`
`Yes
`
`SIGNATURE SECTION
`
`

`

`RESPONSE SIGNATURE
`
`SIGNATORY'S NAME
`
`SIGNATORY'S POSITION
`
`SIGNATORY'S PHONE NUMBER
`
`DATE SIGNED
`
`AUTHORIZED SIGNATORY
`
`FILING INFORMATION SECTION
`
`SUBMIT DATE
`
`TEAS STAMP
`
`/Martin W. Schiffmiller/
`
`Martin W. Schiffmiller
`
`Attorney
`
`212-697-3750
`
`11/29/2018
`
`YES
`
`Thu Nov 29 07:58:29 EST 2018
`
`USPTO/ROA-XX.XX.XXX.XXX-2
`0181129075829800924-79232
`007-6104c1689ffc74bbd7385
`81452174539ec9f5f8f8b4b18
`a6f6433d9ae651b541aae-N/A
`-N/A-20181129075554092104
`
`Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`PTO Form 1957 (Rev 10/2011)
`
`OMB No. 0651-0050 (Exp 09/20/2020)
`
`To the Commissioner for Trademarks:
`
`Response to Office Action
`
`Application serial no. 79232007 AMIDI(Standard Characters, see https://tmng-al.uspto.gov/resting2/api/img/79232007/large) has been amended
`as follows:
`
`CLASSIFICATION AND LISTING OF GOODS/SERVICES
`Applicant proposes to amend the following class of goods/services in the application:
`Current: Class 042 for Providing scientific and technological services and research and design relating thereto, namely, research and design in
`the field of in-vitro diagnostics, medical research and scientific research information in the field of pharmaceuticals and clinical trials; medical
`research and scientific study and research, namely, scientific and biotechnological facilities and research for the health care with regard to the
`production, validation, development, storage, transport, and use in an electronic device, consisting of one or more chips, integrated
`pharmaceutical compositions and in-vitro analysis - and diagnostic tools; designing, installing, maintaining, developing and updating software,
`mobile software applications and computer software platforms; consultancy and providing information regarding the aforesaid services, including
`provided via electronic networks such as the internet
`Original Filing Basis:
`Filing Basis Section 66(a) , Request for Extension of Protection to the United States. Section 66(a) of the Trademark Act, 15 U.S.C. §1141f.
`
`Proposed:
`Tracked Text Description: Providing scientific and technological services and research and design relating thereto, namely, research and
`design in the field of in-vitro diagnostics, medical research and scientific research information in the field of pharmaceuticals and clinical trials;
`medical research and scientific study and research, namely, scientific and biotechnological facilities and research for the health care with regard
`to the production, validation, development, storage, transport, and use in an electronic device, consisting of one or more chips, integrated
`pharmaceutical compositions and in-vitro analysis - and diagnostic tools; medical research and scientific study and research in scientific and
`biotechnological facilities, namely, research in health care with regard to the production, validation, development, storage, transport, and use of
`an electronic device consisting of one or more chips, integrated pharmaceutical compositions and in-vitro analysis, and diagnostic tools;
`designing, installing, maintaining, developing and updating software, mobile software applications and computer software platforms; consultancy
`and providing information regarding the aforesaid services, including provided via electronic networks such as the internet
`
`Class 042 for Providing scientific and technological services and research and design relating thereto, namely, research and design in the field of
`in-vitro diagnostics, medical research and scientific research information in the field of pharmaceuticals and clinical trials; medical research and
`scientific study and research in scientific and biotechnological facilities, namely, research in health care with regard to the production, validation,
`development, storage, transport, and use of an electronic device consisting of one or more chips, integrated pharmaceutical compositions and in-
`
`

`

`vitro analysis, and diagnostic tools; designing, installing, maintaining, developing and updating software, mobile software applications and
`computer software platforms; consultancy and providing information regarding the aforesaid services, including provided via electronic networks
`such as the internet
`
`Filing Basis Section 66(a) , Request for Extension of Protection to the United States. Section 66(a) of the Trademark Act, 15 U.S.C. §1141f.
`
`ATTORNEY ADDRESS
`Applicant proposes to amend the following:
`Proposed:
`Martin W. Schiffmiller of Kirschstein Israel Schiffmiller & Pieron, having an address of
`425 Fifth Avenue 5th Floor, Suite 501 New York, New York 10016-2223
`United States
`mws@kirschsteinlaw.com
`2126973750
`2125079153
`The Other Appointed Attorney(s): Alan Israel and Lisa A. Pieroni.
`
`CORRESPONDENCE ADDRESS CHANGE
`Applicant proposes to amend the following:
`Current:
`GEVERS
`Holidaystraat 5
`1831 Diegem
`BE
`
`Proposed:
`Martin W. Schiffmiller of Kirschstein Israel Schiffmiller & Pieron, having an address of
`425 Fifth Avenue 5th Floor, Suite 501 New York, New York 10016-2223
`United States
`mws@kirschsteinlaw.com
`2126973750
`2125079153
`
`ADDITIONAL STATEMENTS
`Translation
`The wording AMIDI has no meaning in a foreign language.
`
`Significance of wording, letter(s), or numeral(s)
`AMIDI appearing in the mark has no significance nor is it a term of art in the relevant trade or industry or as used in connection with the
`goods/services/collective membership organization listed in the application, or any geographical significance.
`
`SIGNATURE(S)
`Response Signature
`Signature: /Martin W. Schiffmiller/     Date: 11/29/2018
`Signatory's Name: Martin W. Schiffmiller
`Signatory's Position: Attorney
`
`Signatory's Phone Number: 212-697-3750
`
`The signatory has confirmed that he/she is an attorney who is a member in good standing of the bar of the highest court of a U.S. state, which
`includes the District of Columbia, Puerto Rico, and other federal territories and possessions; and he/she is currently the owner's/holder's attorney
`or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another U.S. attorney or a Canadian attorney/agent
`not currently associated with his/her company/firm previously represented the owner/holder in this matter: (1) the owner/holder has filed or is
`concurrently filing a signed revocation of or substitute power of attorney with the USPTO; (2) the USPTO has granted the request of the prior
`representative to withdraw; (3) the owner/holder has filed a power of attorney appointing him/her in this matter; or (4) the owner's/holder's
`appointed U.S. attorney or Canadian attorney/agent has filed a power of attorney appointing him/her as an associate attorney in this matter.
`
`

`

`Mailing Address:    Martin W. Schiffmiller
`   Kirschstein Israel Schiffmiller & Pieron
`   425 Fifth Avenue 5th Floor, Suite 501
`   New York, New York 10016-2223
`
`Serial Number: 79232007
`Internet Transmission Date: Thu Nov 29 07:58:29 EST 2018
`TEAS Stamp: USPTO/ROA-XX.XX.XXX.XXX-2018112907582980
`0924-79232007-6104c1689ffc74bbd738581452
`174539ec9f5f8f8b4b18a6f6433d9ae651b541aa
`e-N/A-N/A-20181129075554092104
`
`        
`